BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25528467)

  • 1. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.
    Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
    BMC Infect Dis; 2014 Dec; 14():3860. PubMed ID: 25528467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study.
    Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
    BMC Med; 2015 Apr; 13():70. PubMed ID: 25889688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
    Van Rie A; Westreich D; Sanne I
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.
    Ndlovu Z; Chirwa T; Takuva S
    Pan Afr Med J; 2014; 19():114. PubMed ID: 25722787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic alterations and early mortality in a cohort of HIV positive African patients.
    Ciccacci F; Lucaroni F; Latagliata R; Morciano L; Mondlane E; Balama M; Tembo D; Gondwe J; Orlando S; Palombi L; Marazzi MC
    PLoS One; 2020; 15(11):e0242068. PubMed ID: 33170905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
    Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.
    Lawn SD; Myer L; Edwards D; Bekker LG; Wood R
    AIDS; 2009 Aug; 23(13):1717-25. PubMed ID: 19461502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
    Zhou J; Jaquet A; Bissagnene E; Musick B; Wools-Kaloustian K; Maxwell N; Boulle A; Wehbe F; Masys D; Iriondo-Perez J; Hemingway-Foday J; Law M;
    J Int AIDS Soc; 2012 Jan; 15(1):5. PubMed ID: 22289654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo.
    Akilimali PZ; Kashala-Abotnes E; Musumari PM; Kayembe PK; Tylleskar T; Mapatano MA
    PLoS One; 2015; 10(10):e0140240. PubMed ID: 26474481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
    J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China.
    Mijiti P; Yuexin Z; Min L; Wubuli M; Kejun P; Upur H
    Int J STD AIDS; 2015 Mar; 26(3):156-64. PubMed ID: 24810220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaemia in HIV-infected children: severity, types and effect on response to HAART.
    Nyesigire Ruhinda E; Bajunirwe F; Kiwanuka J
    BMC Pediatr; 2012 Oct; 12():170. PubMed ID: 23114115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.